Page not found
The page you're trying to reach is unavailable or may no longer exist.
To find what you're looking for, please see the site map below.
LENVIMA is a prescription medicine that is used to treat certain kinds of cancer.
- LENVIMA is used by itself to treat differentiated thyroid cancer (DTC), a type of thyroid cancer that can no longer be treated with radioactive iodine and is progressing.
- LENVIMA is used to treat adults with a type of kidney cancer called advanced renal cell carcinoma (RCC):
- along with the medicine pembrolizumab as your first treatment when your kidney cancer has spread or cannot be removed by surgery.
- along with the medicine everolimus after one course of treatment with another anti-cancer medicine.
- LENVIMA is used by itself as the first treatment for a type of liver cancer called hepatocellular carcinoma (HCC) when it cannot be removed by surgery.
- LENVIMA is used along with another medicine called pembrolizumab to treat advanced endometrial carcinoma (EC), a type of uterine cancer:
- when a laboratory test shows that your tumor is mismatch repair proficient (pMMR) or not microsatellite instability high (MSI-H), and
- you have received anti-cancer treatment, and it is no longer working, and
- your cancer cannot be cured by surgery or radiation
It is not known if LENVIMA is safe and effective in children.
View full indication
Select cancer type
-
Differentiated thyroid
cancer (DTC) -
Advanced kidney cancer (RCC)
as your first treatment* -
Advanced kidney cancer (RCC)
after 1 previous treatment† -
Inoperable liver cancer (HCC)
-
Advanced endometrial cancer*
*Taken in combination with pembrolizumab.
†Taken in combination with everolimus after one course of treatment with another anti-cancer medicine.